We are live on ! Find out more
ATCO

Atlas Corp.

Delisted

ATCO was delisted on the 27th of March, 2023.

97 hedge funds and large institutions have $129M invested in Atlas Corp. in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 23

3% more capital invested

Capital invested by funds: $126M → $129M (+$3.61M)

7% less funds holding

Funds holding: 10497 (-7)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

82% less call options, than puts

Call options by funds: $633K | Put options by funds: $3.58M

Holders
97
Holders Change
-7
Holders Change %
-6.73%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
38
Reduced
23
Closed
21
Calls
$633K
Puts
$3.58M
Net Calls
-$2.95M
Net Calls Change
-$1.02M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
$41.7M +$7.46M +1,143,815 +23%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$11M +$302K +46,267 +3%
PAIM
3
Punch & Associates Investment Management
Minnesota
$6.23M +$1.85M +283,461 +44%
HCM
4
Highbridge Capital Management
New York
$5.2M +$322K +49,300 +7%
FCIM
5
Fairview Capital Investment Management
California
$4.74M -$3.86M -591,237 -46%
MVP
6
Miller Value Partners
Florida
$4.38M +$82.7K +12,680 +2%
PM
7
Parametrica Management
Hong Kong
$3.99M -$173K -26,560 -4%
Two Sigma Investments
8
Two Sigma Investments
New York
$3.42M +$3.18M +487,423 +2,436%
GC
9
Guggenheim Capital
Illinois
$3.07M -$192K -29,442 -6%
First Trust Advisors
10
First Trust Advisors
Illinois
$2.88M +$113K +17,268 +4%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$2.87M +$1.8M +275,672 +184%
GGHC
12
Gilder Gagnon Howe & Co
New York
$2.76M +$2.67M +408,777 New
State Street
13
State Street
Massachusetts
$2.62M +$406K +62,221 +19%
BlackRock
14
BlackRock
New York
$2.31M +$29.8K +4,573 +1%
Schroder Investment Management Group
15
Schroder Investment Management Group
United Kingdom
$2.2M +$2.12M +325,600 New
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$2.02M +$898K +137,665 +85%
Goldman Sachs
17
Goldman Sachs
New York
$1.88M -$3.24M -496,859 -64%
UBS Group
18
UBS Group
Switzerland
$1.84M +$133K +20,390 +8%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$1.61M +$208K +31,934 +15%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$1.45M +$1.23M +189,205 +760%
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.42M +$121K +18,552 +10%
SGA
22
Strategic Global Advisors
California
$998K
Bank of Montreal
23
Bank of Montreal
Ontario, Canada
$931K +$45.8K +7,012 +5%
LPL Financial
24
LPL Financial
California
$898K +$49.1K +7,524 +6%
Citadel Advisors
25
Citadel Advisors
Florida
$868K +$684K +104,791 +439%

ATCO Hedge Fund Activity: Q4 2017 in Review

97 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Atlas Corp. (ATCO) for Q4 2017, worth a combined $129M — up 2.9% from $126M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ATCO and 15 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 38 added.

The largest buyer was Invesco, adding an estimated $7.46M. The largest seller was Fairview Capital Investment Management, cutting an estimated $3.86M.

  • 97 institutional investors held Atlas Corp. (ATCO) as of Q4 2017, down from 104 in Q3 2017.
  • Funds reported $129M of Atlas Corp. stock for Q4 2017, up 2.9% quarter-over-quarter.
  • 15 funds opened new Atlas Corp. positions in Q4 2017 and 21 closed out, a net change of -6 holders.
  • The largest Atlas Corp. buyer in Q4 2017 was Invesco, an estimated $7.46M added.
  • The largest Atlas Corp. seller in Q4 2017 was Fairview Capital Investment Management, an estimated $3.86M sold.

Based on aggregated 13F filings for Q4 2017.